UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042691
Receipt number R000048717
Scientific Title Effects of auditory stimulation on sleep during nap
Date of disclosure of the study information 2020/12/08
Last modified on 2020/12/08 18:32:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of auditory stimulation on sleep
during nap

Acronym

Effects of auditory stimulation on sleep
during nap

Scientific Title

Effects of auditory stimulation on sleep
during nap

Scientific Title:Acronym

Effects of auditory stimulation on sleep
during nap

Region

Japan


Condition

Condition

Healthy subject

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to evaluate the slow wave sleep latency effected by continuous auditory stimulation ( 0.25Hz or 1Hz binaural beat ) during daytime nap.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Slow wave sleep latency

Key secondary outcomes

1) Sleep variables other than slow wave sleep latency obtained by polysomnography
2)Heart rate variability during nap
3)Psychomotor vigilance test performance
4)Subjective sleepiness and mood


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

A.Sham (no sound)

Interventions/Control_2

B.250-250Hz (0Hz pure tone)

Interventions/Control_3

C.250-250.25Hz (0.25Hz binaural beat)

Interventions/Control_4

D.250-251Hz (1Hz binaural beat)

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

Participants will be included on the following all criteria.
1) Not having difficulty in filling out Japanese explanatory documents, consent forms, and survey forms
2) Being able to stay in the examination room on the 5th floor or the mobile human sleep laboratory of the Innovative Medical Research Institute, University of Tsukuba.
3) Having no sleep disorder currently being treated
4) Having no hearing impairment in daily life

Key exclusion criteria

Participants will be excluded from the experiment based on the following criteria.
1)Irregular lifestyle (Regular: sleep time between 9pm and 1am, wake time between 6am and 9am, 7-9 hours of sleep)
2)BMI less than 18.5 or greater than 25
3)Worked night shifts (after 10pm) 3 months prior to the experiment
4)Travel across time zones with time difference of 3 hours or more, 3 months prior to the experiment
5) Consumes alcohol regularly (40g (2 cans of beer) or more twice a week a more)
6) Smoker
7) Consumes more than 300mg (5 cups of 150mL) of coffee every day
8) MEQ score of less than 30 (extreme evening type) or greater than 70 (extreme morning type)
9) Pittsburgh Sleep Quality Index score of greater than 5.5
10) Those who cannot perceive the frequency difference of the binaural beats and feel uncomfortable when listening to the auditory stimulation samples of this experiment.
11)Claustrophobic
12)Pregnancy or its possibility
13)Lactation
14)Those who have a disease that may change suddenly or its history
15)Those who have been treated for psychiatric disorders or sleep disorders, and those who have symptoms that are currently being treated
16)Subjects judged by the investigator to be inappropriate

Target sample size

12


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Abe

Organization

University of Tsukuba

Division name

International Institute for Integrative Sleep Medicine (WPI-IIIS)

Zip code

305-8575

Address

1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan

TEL

029-859-1858

Email

abe.takashi.gp@u.tsukuba.ac.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Abe

Organization

University of Tsukuba

Division name

International Institute for Integrative Sleep Medicine (WPI-IIIS)

Zip code

305-8575

Address

1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan

TEL

029-859-1858

Homepage URL


Email

abe.takashi.gp@u.tsukuba.ac.jp


Sponsor or person

Institute

University of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

Kyocera Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Kyocera Corporation

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tsukuba Clinical Research & Development Organization

Address

2-1-1 Amakubo, Tsukuba, Ibaraki 305-8576 Japan

Tel

029-853-3914

Email

jisedai@md.tsukuba.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 12 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2020 Year 11 Month 18 Day

Date of IRB


Anticipated trial start date

2021 Year 01 Month 11 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 12 Month 08 Day

Last modified on

2020 Year 12 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048717


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name